4-Arylpyridines as selective c-jun-N-terminal kinase-3 (JNK-3) inhibitors

被引：0
|
作者：
Plobeck, N
Swahn, BM
Viklund, J
Xue, Y
机构：
[1] AstraZeneca, R&D Sodertalje, Dept Med Chem, SE-15185 Sodertalje, Sweden
[2] AstraZeneca Molndal, Struct Chem Lab, Molndal, Sweden
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
380-MEDI
引用
收藏
页码：U2717 / U2718
页数：2
相关论文
共 50 条
  • [21] C-Jun N-terminal kinase 3 (JNK3) as target for halogen bonding
    Lange, Andreas
    Guenther, Marcel
    Laufer, Stefan A.
    Boeckler, Frank M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [22] Protein Kinase C (PKC) Participates in Acetaminophen Hepatotoxicity Through c-jun-N-terminal Kinase (JNK)-Dependent and -Independent Signaling Pathways
    Saberi, Behnam
    Ybanez, Maria D.
    Johnson, Heather S.
    Gaarde, William A.
    Han, Derick
    Kaplowitz, Neil
    HEPATOLOGY, 2014, 59 (04) : 1543 - 1554
  • [23] Modeling and Benchmark Data Set for the inhibition of c-Jun N-terminal Kinase-3
    Schattel, Verena
    Hinselmann, Georg
    Jahn, Andreas
    Zell, Andreas
    Laufer, Stefan
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (03) : 670 - 679
  • [24] Insights into the c-Jun N-terminal kinase 3 (JNK3) inhibitors: CoMFA, CoMSIA analyses and molecular docking studies
    Liu, Yanda
    Xie, Yewei
    Liu, Yuanyuan
    Wang, Pengcheng
    Ye, Jiaxi
    Su, Yalun
    Liang, Zhihong
    He, Zhaohui
    Zhou, Haibo
    Liao, Guochao
    Xu, Jun
    Chang, Yiqun
    Sun, Pinghua
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (10) : 1796 - 1805
  • [25] Insights into the c-Jun N-terminal kinase 3 (JNK3) inhibitors: CoMFA, CoMSIA analyses and molecular docking studies
    Yanda Liu
    Yewei Xie
    Yuanyuan Liu
    Pengcheng Wang
    Jiaxi Ye
    Yalun Su
    Zhihong Liang
    Zhaohui He
    Haibo Zhou
    Guochao Liao
    Jun Xu
    Yiqun Chang
    Pinghua Sun
    Medicinal Chemistry Research, 2019, 28 : 1796 - 1805
  • [26] FK866 attenuates acute hepatic failure through c-jun-N-terminal kinase (JNK)-dependent autophagy
    Enshuang Guo
    Renlong Li
    Jiankun Yang
    Jun Zhang
    Anyi Li
    Yan Yang
    Shenpei Liu
    Anding Liu
    Xiaojing Jiang
    Scientific Reports, 7
  • [27] FK866 attenuates acute hepatic failure through c-jun-N-terminal kinase (JNK)-dependent autophagy
    Guo, Enshuang
    Li, Renlong
    Yang, Jiankun
    Zhang, Jun
    Li, Anyi
    Yang, Yan
    Liu, Shenpei
    Liu, Anding
    Jiang, Xiaojing
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors
    Fricker, M
    LoGrasso, P
    Ellis, S
    Wilkie, N
    Hunt, P
    Pollack, SJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 438 (02) : 195 - 205
  • [29] The c-Jun-N-terminal kinase is involved in the neurotoxic effect of azaspiracid-1
    Vale, Carmen
    Gomez-Limia, Belen
    Nicolaou, K. C.
    Frederick, Michael O.
    Vieytes, Mercedes R.
    Botana, Luis M.
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2007, 20 (06) : 957 - 966
  • [30] Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration
    Probst, Gary D.
    Bowers, Simeon
    Sealy, Jennifer M.
    Truong, Anh P.
    Hom, Roy K.
    Galemmo, Robert A., Jr.
    Konradi, Andrei W.
    Sham, Hing L.
    Quincy, David A.
    Pan, Hu
    Yao, Nanhua
    Lin, May
    Toth, Gergley
    Artis, Dean R.
    Zmolek, Wes
    Wong, Karina
    Qin, Ann
    Lorentzen, Colin
    Nakamura, David F.
    Quinn, Kevin P.
    Sauer, John-Michael
    Powell, Kyle
    Ruslim, Lany
    Wright, Sarah
    Chereau, David
    Ren, Zhao
    Anderson, John P.
    Bard, Frederique
    Yednock, Ted A.
    Griswold-Prenner, Irene
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 315 - 319
12345